MCID: SCL003
MIFTS: 48

Social Phobia malady

Category: Mental diseases

Aliases & Classifications for Social Phobia

About this section

Aliases & Descriptions for Social Phobia:

Name: Social Phobia 11 13
Phobic Anxiety Disorder 67
Phobic Disorders 38
 
Phobia, Social 67
Phobia Social 49

Classifications:



External Ids:

Disease Ontology11 DOID:11257
ICD9CM31 300.23
MeSH38 D010698
NCIt44 C34927

Summaries for Social Phobia

About this section
Disease Ontology:11 A phobic disorder that involves social anxiety occurring only in specific public or social situations, interactions with others or being evaluated or scrutinized by other people.

MalaCards based summary: Social Phobia, also known as phobic anxiety disorder, is related to strabismus and sexual disorder, and has symptoms including child behavior symptom/complaint, death anxiety and death anxiety. An important gene associated with Social Phobia is MAOA (Monoamine Oxidase A), and among its related pathways are Monoamine Transport and SIDS Susceptibility Pathways. The drugs paroxetine hydrochloride and paroxetine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and amygdala, and related mouse phenotypes are endocrine/exocrine gland and behavior/neurological.

Related Diseases for Social Phobia

About this section

Diseases related to Social Phobia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 102)
idRelated DiseaseScoreTop Affiliating Genes
1strabismus29.9DRD2, PRL
2sexual disorder29.0DRD2, MAOA, SLC6A4
3avoidant personality disorder28.9CCK, DRD2, MAOA, PRL, SLC6A4
4schizophrenia27.5CCK, DRD2, HTR3A, MAOA, PRL, SLC6A4
5phobic disorder12.1
6personality disorder10.5
7anxiety disorder10.5
8panic disorder10.4
9intrahepatic gall duct cancer10.3MAOA, SLC6A4
10agoraphobia10.3
11chagas disease10.3MAOA, SLC6A4
12generalized anxiety disorder10.3
13pyromania10.3MAOA, SLC6A4
14aphasia10.3MAOA, PRL
15vogt-koyanagi-harada disease10.3MAOA, SLC6A4
16lymphadenitis10.3MAOA, SLC6A4
17obsessive-compulsive personality disorder10.2MAOA, SLC6A4
18obsessive-compulsive disorder10.2
19hypoglycemic coma10.2MAOA, SLC6A4
20dental fluorosis10.2HTR3A, SLC6A4
21malt worker's lung10.2CCK, PRL
22mutism10.1
23meckel's diverticulum10.0MAOA, PRL, SLC6A4
24ring staphyloma10.0CCK, HTR3A
25erysipelas10.0DRD2, PRL
26symmastia10.0DRD2, PRL
27acute female pelvic peritonitis10.0DRD2, MAOA
28basal cell carcinoma10.0DRD2, SLC6A4
29phobia, specific10.0
30body dysmorphic disorder10.0
31separation anxiety disorder10.0
32splenic disease10.0DRD2, SLC6A4
33idiopathic neonatal atrial flutter10.0HTR3A, MAOA, SLC6A4
34cold-induced sweating syndrome 29.9DRD2, PRL
35nonencapsulated sclerosing carcinoma9.9MAOA, PTK7, SLC6A4
36malignant peripheral nerve sheath tumor9.9MAOA, PTK7, SLC6A4
37mixed malaria9.9HTR3A, MAOA, SLC6A4
38hereditary neuropathies9.9CCK, HTR3A
39pyoderma gangrenosum9.9HTR3A, MAOA, SLC6A4
40anosognosia9.9DRD2, SLC6A4
41ulcerative colitis9.9DRD2, SLC6A4
42sudden infant death syndrome9.9HTR3A, MAOA, SLC6A4
43spinal muscular atrophy, distal, x-linked 39.9CCK, PRL
44autoimmune-related retinopathy and optic neuropathy9.9HTR3A, SLC6A4
45acne9.9
46premature ejaculation9.9
47mood disorder9.9
48drug dependence9.9
49elective mutism9.9
50pelvic inflammatory disease9.8DRD2, SLC6A4

Comorbidity relations with Social Phobia via Phenotypic Disease Network (PDN):


Anxiety DisorderDysthymic Disorder

Graphical network of the top 20 diseases related to Social Phobia:



Diseases related to social phobia

Symptoms for Social Phobia

About this section

UMLS symptoms related to Social Phobia:


child behavior symptom/complaint, death anxiety, unreasonable fear of injury related events, unreasonable fear of seeing an injury

Drugs & Therapeutics for Social Phobia

About this section

Drugs for Social Phobia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 205)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CycloserineapprovedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 110668-41-7401, 6234
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-Cycloserine
1pb9
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, D
30020_FLUKA
30020_SIGMA
4-27-00-05549 (Beilstein Handbook Reference)
4AX
68-41-7
AB00443920
AC-4721
AC1L1M33
AC1Q4UA7
AI3-50153
BB_NC-1631
BIDD:GT0707
BPBio1_001252
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
C3909_SIGMA
C3H6N2O2
C6880_SIGMA
C7670_SIGMA
CAS-339-72-0
CAS-68-41-7
CHEBI:40009
CHEMBL771
CID6234
CPD-2482
CPD000058313
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
Cyclo-D-serine
Cyclorin
Cycloserine
Cycloserine (JP15/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-Isoxazolidinone
D-4-amino-3-Isoxazolidone
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-CS
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D-amino-3-isoxazolidinone
D-cycloserine
D00877
DB03123
DCS
DL-Cycloserine
DRG-0195
DivK1c_000098
E-733-A
EINECS 200-688-4
 
EU-0100252
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS500E20
HSDB 3218
I-1431
IDI1_000098
K-300
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
L-Cycloserine
LMPK14000007
LS-86757
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
MLS000758215
MLS001423962
Micoserina
Miroserina
Miroseryn
MolPort-000-858-643
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-05
NCGC00093713-01
NCGC00093713-02
NINDS_000098
NSC 154851
Novoserin
Orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
R(+)-4-Amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
RO-1-9213
Ro-1-9213
S1998_Selleck
SAM001247014
SAM002264599
SC-49088
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
SPECTRUM1500215
Seromycin
Seromycin (TN)
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
Spectrum_000860
Tebemicina
Tisomycin
UNII-95IK5KI84Z
Wasserina
alpha-Cycloserine
cyclo-D-Serine
cycloserine
orientomycin
α-Cycloserine
2
CitalopramapprovedPhase 4, Phase 2, Phase 3, Phase 150359729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
3
SertralineapprovedPhase 4, Phase 3, Phase 2, Phase 129579617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
4
NorepinephrineapprovedPhase 4, Phase 368351-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
5
DopamineapprovedPhase 4, Phase 3, Phase 2375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
6
Paroxetineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 122661869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
7PiracetamapprovedPhase 4, Phase 21707491-74-9
8
TiagabineapprovedPhase 420115103-54-360648
Synonyms:
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
115103-54-3
A-70569-1
ABBOTT-70569-1
AC-7048
AC1L1TNE
AC1Q5R43
BIDD:GT0018
C07503
C20H25NO2S2
CHEBI:222170
CHEMBL1027
CID60648
D08588
DB00906
 
Gabitril
Gabitril (TN)
HSDB 7527
LS-114651
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
NCGC00164626-01
NO 329
NO-328
NO-329
Tiagabina
Tiagabina [INN-Spanish]
Tiagabine (INN)
Tiagabine [INN:BAN]
Tiagabine [INN]
Tiagabinum
Tiagabinum [INN-Latin]
UNII-Z80I64HMNP
tiagabine
9
Clonazepamapproved, illicitPhase 4311622-61-32802
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
CID2802
CLONAZEPAM
Chlonazepam
Cloazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
DB01068
DEA No. 2737
 
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
LS-34156
LS-34260
Landsen
Lktorivil
Lonazep
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
RO4023
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
clonazepam
10
Aripiprazoleapproved, investigationalPhase 4353129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify Discmelt
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
CPD000466383
 
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
11
Lidocaineapproved, vet_approvedPhase 41226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
12
Acamprosateapproved, investigationalPhase 43977337-76-971158
Synonyms:
3-(Acetylamino)propanesulphonic acid
3-Acetamido-1-propanesulfonic acid
3-acetamidopropane-1-sulfonic acid
77337-70-3 (mono-hydrochloride salt)
77337-71-4 (mono-potassium salt)
77337-72-5 (mono-lithium salt)
77337-73-6 (calcium[2:1] salt)
77337-74-7 (magnesium[2:1] salt)
77337-76-9
AC1L2FNA
AC1Q1L6O
AC1Q6X8K
AOTA
AR-1H6082
Acamprosate
Acamprosate (INN)
Acamprosate 6473
Acamprosate [INN:BAN]
Acamprosato
Acamprosato [INN-Spanish]
Acamprosatum
 
Acamprosatum [INN-Latin]
Aotal
Aotal (TN)
C5H11NO4S
CHEBI:51041
CID71158
Campral
D07058
DB00659
EINECS 278-667-4
HSDB 7358
LS-120940
N-Acetylhomotaurine
N-acetyl homotaurine
UNII-N4K14YGM3J
acamprosate
acamprosate (Campral)
acamprostate
calcium acetyl homotaurinate
calcium acetylhomotaurinate
calcium acetylhomotaurine
sodium acetylhomotaurine
13
Propranololapproved, investigationalPhase 4, Phase 2, Phase 3216525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
14
EthanolapprovedPhase 4, Phase 2204364-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
15
TopiramateapprovedPhase 424797240-79-45284627
Synonyms:
-D-fructopyranose deriv.
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
CPD000466325
Cilag brand of topiramate
D00537
DB00273
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
MLS000759431
MLS001424070
McN 4853
McN-4853
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
 
Ortho brand of topiramate
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
STOCK1N-71037
Spectrum2_001128
T0575_SIGMA
TL8006021
TOR
TPM
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Topamac
Topamax
Topamax (TN)
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
UNII-0H73WJJ391
USL-255
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
topiramate
topiramate tablet
topiramatum [Latin]
16
VortioxetineapprovedPhase 462508233-74-79966051
Synonyms:
4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium
 
BRINTELLIX
vortioxetine cation
17
Tetracaineapproved, vet_approvedPhase 48594-24-65411
Synonyms:
136-47-0 (mono-hydrochloride)
2-(Dimethylamino)ethyl 4-(butylamino)benzoate
2-(Dimethylamino)ethyl p-(butylamino)benzoate
2-(dimethylamino)ethyl 4-(butylamino)benzoate
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]
2-dimethylaminoethyl 4-(butylamino)benzoate
4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
4-14-00-01172 (Beilstein Handbook Reference)
4-[Butylamino]benzoic acid-2-[dimethylamino]ethyl ester
94-24-6
AB00053549
AC-3480
AC1L1KAQ
Amethocaine
Amethocaine (TN)
Amethocaine HCl
Anetain
BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER
BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
BPBio1_000422
BRD-K45071273-003-05-8
BRN 2216051
BSPBio_000382
BSPBio_001944
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester
C07526
C15H24N2O2
CAS-136-47-0
CHEBI:9468
CHEMBL698
CID5411
Contralgin
D00551
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]
Dicain
Dicaine
Dikain
Dimethylaminoethyl p-butyl-aminobenzoate
DivK1c_000607
Diäthylaminoäthanol ester der p-butylaminobenzösäure
EINECS 202-316-6
Fissucain
I01-1872
IDI1_000607
InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H
Intercain
KBio1_000607
KBio2_001512
KBio2_004080
KBio2_006648
 
KBio3_001444
KBioGR_000781
KBioSS_001512
LS-36312
Laudocaine
Lopac-T-7508
Lopac0_001211
Medicaine
Medihaler-Tetracaine
Meethobalm
Metraspray
MolPort-001-783-476
Mucaesthin
NCGC00016049-01
NCGC00016049-02
NCGC00016049-04
NCGC00162367-01
NINDS_000607
Niphanoid
Pontocaine
Pontocaine HCl
Prestwick0_000571
Prestwick1_000571
Prestwick2_000571
Prestwick3_000571
Rexocaine
SBB058194
SPBio_001455
SPBio_002601
Spectrum2_001328
Spectrum3_000562
Spectrum4_000351
Spectrum5_001072
Spectrum_001032
T3812_SIAL
T7383_SIAL
T7383_SIGMA
Tetracaina
Tetracaina [INN-Spanish]
Tetracaine (USP/INN)
Tetracaine HCl
Tetracaine [USAN:INN]
Tetracainum
Tetracainum [INN-Latin]
Tetracaína
Tetrakain
Tetrakain [Czech]
Tétracaïne
UNII-0619F35CGV
Uromucaesthin
p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester
p-(butylamino)benzoic acid β-(dimethylamino)ethyl ester
p-Butylaminobenzoyl-2-dimethylaminoethanol
tetracaine
18Autonomic AgentsPhase 4, Phase 2, Phase 3, Phase 19774
19Antiparkinson AgentsPhase 4, Phase 2, Phase 3, Phase 11527
20Cholinergic AgentsPhase 4, Phase 2, Phase 3, Phase 13846
21Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 122776
22Anti-Anxiety AgentsPhase 4, Phase 3, Phase 2, Phase 11816
23Adrenergic AgentsPhase 4, Phase 3, Phase 25140
24Serotonin 5-HT1 Receptor AgonistsPhase 4203
25Quetiapine FumaratePhase 4, Phase 3, Phase 2, Early Phase 1413111974-72-2
26ParasympatholyticsPhase 4, Phase 2, Phase 3, Phase 11050
27Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 112806
28Muscarinic AntagonistsPhase 4, Phase 2, Phase 3, Phase 11134
29Cholinergic AntagonistsPhase 4, Phase 2, Phase 3, Phase 11658
30AnalgesicsPhase 4, Phase 3, Phase 2, Early Phase 111287
31
SerotoninPhase 4, Phase 3, Phase 2, Phase 1356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
32Serotonin AgentsPhase 4, Phase 3, Phase 2, Phase 13102
33Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 11570
34Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 110884
35Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 13464
36Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 117734
37Tranquilizing AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14164
38Antidepressive AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 12666
39Antidepressive Agents, Second-GenerationPhase 4, Phase 2, Phase 3, Phase 11287
40Antipsychotic AgentsPhase 4, Phase 3, Phase 2, Early Phase 12359
41Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 121402
42Antibiotics, AntitubercularPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16972
43Renal AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1732
44GABA AgentsPhase 4, Phase 2, Phase 11622
45GABA ModulatorsPhase 4, Phase 1864
46Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16279
47AnticonvulsantsPhase 4, Phase 2, Phase 32620
48Antitubercular AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11272
49AntimetabolitesPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 111774
50Antihypertensive AgentsPhase 4, Phase 2, Phase 34095

Interventional clinical trials:

(show top 50)    (show all 310)
idNameStatusNCT IDPhase
1Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in AdultsUnknown statusNCT01224067Phase 4
2The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking EnvironmentCompletedNCT00407199Phase 4
3RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and PlaceboCompletedNCT00184106Phase 4
4D-Cycloserine Enhancement of Exposure in Social PhobiaCompletedNCT00633984Phase 4
5Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety DisorderCompletedNCT00282828Phase 4
6Nefazodone in the Treatment of Social PhobiaCompletedNCT00231348Phase 4
7Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and AdolescentsCompletedNCT01160588Phase 4
8Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety DisorderCompletedNCT00872131Phase 4
912-Week Study of Pristiq (Desvenlafaxine) Social Anxiety DisorderCompletedNCT01316302Phase 4
10Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic DisorderCompletedNCT00265109Phase 4
11Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic DisorderCompletedNCT00767871Phase 4
12Paroxetine for Comorbid Social Anxiety Disorder and AlcoholismCompletedNCT00246441Phase 4
13Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety DisorderCompletedNCT00208741Phase 4
14Escitalopram in Patients With Social Anxiety DisorderCompletedNCT00902226Phase 4
15Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety DisorderCompletedNCT00190879Phase 4
16Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietyCompletedNCT00177008Phase 4
17Primary Care Intervention Strategy for Anxiety DisordersCompletedNCT00347269Phase 4
18Acamprosate in Alcoholics With Comorbid Anxiety or DepressionCompletedNCT00330174Phase 4
19Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)RecruitingNCT00182455Phase 4
20Brief Intervention to Reduce Fear of Public SpeakingRecruitingNCT02790736Phase 4
21Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety DisorderActive, not recruitingNCT02294305Phase 4
22Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder ComorbidityActive, not recruitingNCT01863459Phase 4
23Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersEnrolling by invitationNCT00182533Phase 4
24Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle PhobiasTerminatedNCT01623583Phase 4
25Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical PracticeUnknown statusNCT01388231Phase 2, Phase 3
26Child and Adolescent Anxiety Disorders (CAMS)Unknown statusNCT00052078Phase 3
27Study of Escitalopram in the Treatment of Specific PhobiaCompletedNCT00121069Phase 2, Phase 3
28Treatment of Childhood Social PhobiaCompletedNCT00043537Phase 3
29Residential Cognitive and Interpersonal Therapy for Social PhobiaCompletedNCT00326430Phase 2, Phase 3
30A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural TherapyCompletedNCT00564967Phase 3
31Treatment of Social Phobia and Panic Disorder in AdultsCompletedNCT00619138Phase 3
32Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social PhobiaCompletedNCT00515879Phase 3
33Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social AnxietyCompletedNCT00958880Phase 3
34Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic ParticipantsCompletedNCT00734422Phase 2, Phase 3
35Long-term Study Of Paroxetine in Women and MenCompletedNCT00264654Phase 3
36Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic ParticipantsCompletedNCT02007694Phase 2, Phase 3
37D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for AcrophobiaCompletedNCT01102803Phase 3
38Social Anxiety Disorder Study Of ParoxetineCompletedNCT00318669Phase 3
39Flushing in Social Anxiety Disorder on SeroquelCompletedNCT00773162Phase 3
40Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety DisorderCompletedNCT00260533Phase 2, Phase 3
41Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety DisorderCompletedNCT00074802Phase 3
42Quetiapine in Social Anxiety DisorderCompletedNCT00215254Phase 2, Phase 3
43Treatment for Anxiety in ChildrenCompletedNCT00000389Phase 3
44Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health CentersCompletedNCT01416805Phase 3
45St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)CompletedNCT00118833Phase 2, Phase 3
46Virtual Reality Exposure Therapy in Agoraphobic ParticipantsCompletedNCT00734370Phase 2, Phase 3
47Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)CompletedNCT02622958Phase 3
48Treatment of Panic Disorder: Long Term StrategiesCompletedNCT00000368Phase 3
49Duloxetine for Social Anxiety Disorder: Prediction of Long Term OutcomeCompletedNCT00114127Phase 3
50A Systems Level Intervention for Unemployed Persons With Social Anxiety DisorderCompletedNCT01654510Phase 2, Phase 3

Search NIH Clinical Center for Social Phobia

Inferred drug relations via UMLS67/NDF-RT45:


Cochrane evidence based reviews: phobic disorders

Genetic Tests for Social Phobia

About this section

Anatomical Context for Social Phobia

About this section

MalaCards organs/tissues related to Social Phobia:

35
Brain, Testes, Amygdala, Eye, Skin, Lung, Heart

Animal Models for Social Phobia or affiliated genes

About this section

MGI Mouse Phenotypes related to Social Phobia:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053798.5CCK, DRD2, HTR3A, PRL, SLC6A4
2MP:00053868.1CCK, DRD2, HTR3A, MAOA, PRL, SLC6A4
3MP:00053768.0CCK, DRD2, HTR3A, MAOA, PRL, SLC6A4
4MP:00036316.7CCK, DRD2, HTR3A, MAOA, PRL, PTK7

Publications for Social Phobia

About this section

Articles related to Social Phobia:

(show top 50)    (show all 602)
idTitleAuthorsYear
1
Psychometric properties of the mini-social phobia inventory (Mini-SPIN) in a large online treatment-seeking sample. (27046641)
2016
2
Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia. (26288643)
2015
3
Subliminal cues bias perception of facial affect in patients with social phobia: evidence for enhanced unconscious threat processing. (25136307)
2014
4
An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol. (23895258)
2013
5
Stable "trait" variance of temperament as a predictor of the temporal course of depression and social phobia. (24016004)
2013
6
Psychometric properties of the social phobia and anxiety inventory-child version in a Swedish clinical sample. (23933599)
2013
7
Reduced dorsal anterior cingulate cortical activity during emotional regulation and top-down attentional control in generalized social phobia, generalized anxiety disorder, and comorbid generalized social phobia/generalized anxiety disorder. (22592057)
2012
8
Development of a short form Social Interaction Anxiety (SIAS) and Social Phobia Scale (SPS) using nonparametric item response theory: the SIAS-6 and the SPS-6. (21744971)
2012
9
Interpretation of ambiguous social scenarios in social phobia and depression: evidence from event-related brain potentials. (22178443)
2012
10
Childhood history of behavioral inhibition and comorbidity status in 256 adults with social phobia. (20797795)
2011
11
Social phobia and other psychiatric problems in children with strabismus. (21784213)
2011
12
Alternative explanation for FMRI findings in social phobia. (21536704)
2011
13
Task-dependent neural correlates of the processing of verbal threat-related stimuli in social phobia. (20227458)
2010
14
Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review. (20055730)
2010
15
Further study of the psychometric qualities of a brief screening tool for social phobia (MINI-SPIN) applied to clinical and nonclinical samples. (20883433)
2010
16
Evaluation of the psychometric properties of the Social Phobia Inventory in university students. (20965310)
2010
17
Interpretation of positive social events in social phobia: an examination of cognitive correlates and diagnostic distinction. (19942403)
2010
18
Cognitive behavioral group therapy for social phobia with or without attention training: a controlled trial. (19059753)
2009
19
Dreams In Jungian Psychology: The use of Dreams as an Instrument For Research, Diagnosis and Treatment of Social Phobia. (22135511)
2009
20
A demonstration of the efficacy of two of the components of cognitive therapy for social phobia. (19081225)
2009
21
Beyond amygdala: Default Mode Network activity differs between patients with social phobia and healthy controls. (19559343)
2009
22
Shyness 5: the clinical effectiveness of Internet-based clinician-assisted treatment of social phobia. (20001373)
2009
23
Economic costs of social phobia: a population-based study. (19012968)
2009
24
Social phobia in Finnish general adolescent population: prevalence, comorbidity, individual and family correlates, and service use. (19170089)
2009
25
Psychometric properties of the mini-social phobia inventory. (19956461)
2009
26
Assessing post-event processing after social situations: a measure based on the cognitive model for social phobia. (18350392)
2008
27
A new proposal for the subtypes of social phobia in a sample of Spanish adolescents. (17367987)
2008
28
Screening for social phobia in medical in- and outpatients with the German version of the Social Phobia Inventory (SPIN). (17923381)
2008
29
Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. (17976249)
2008
30
Treatment of social phobia through pure self-help and therapist-augmented self-help. (17766766)
2007
31
Temperament and character dimensions in patients with social phobia: patterns of change following treatments? (17328961)
2007
32
Therapeutic factors of cognitive behavioral group treatment for social phobia. (16614524)
2006
33
Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. (16891998)
2006
34
Psychophysiological correlates of face processing in social phobia. (16970928)
2006
35
Specificity of cognitive structure in depression and social phobia: a comparison of interpersonal and achievement content. (16343641)
2006
36
Serotonin uptake to lymphocytes of patients with social phobia compared to normal individuals. (16023834)
2006
37
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. (15930067)
2005
38
Intensive cognitive behavioural group treatment for social phobia: a pilot study. (15844687)
2005
39
Emerging treatments for child and adolescent social phobia: a review. (16190791)
2005
40
Recognition bias for critical faces in social phobia: a replication and extension. (15531356)
2005
41
Pilot study of community-based cognitive behavioral group therapy for adolescents with social phobia. (15725970)
2005
42
EEG mapping in patients with social phobia. (15465293)
2004
43
Social phobia and avoidant personality disorder: one spectrum disorder? (15204221)
2004
44
The nature and expression of social phobia: toward a new classification. (15501556)
2004
45
Changes in self-perception during treatment of social phobia. (15301643)
2004
46
Conquering an Unmasked Social Phobia. (15154025)
2003
47
Childhood stress and symptoms of drug dependence in adolescence and early adulthood: social phobia as a mediator. (9990437)
1999
48
Multimodal comparisons of social phobia subtypes and avoidant personality disorder. (10372342)
1999
49
Avoidant personality disorder and the generalized subtype of social phobia. (1583226)
1992
50
Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. (1525731)
1992

Variations for Social Phobia

About this section

Expression for genes affiliated with Social Phobia

About this section
Search GEO for disease gene expression data for Social Phobia.

Pathways for genes affiliated with Social Phobia

About this section

GO Terms for genes affiliated with Social Phobia

About this section

Cellular components related to Social Phobia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axonGO:00304248.9CCK, DRD2, HTR3A

Biological processes related to Social Phobia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cellular response to retinoic acidGO:00713009.7PTK7, SLC6A4
2response to cocaineGO:00422209.4DRD2, HTR3A

Molecular functions related to Social Phobia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1serotonin bindingGO:005137810.2HTR3A, MAOA
2hormone activityGO:00051799.1CCK, PRL

Sources for Social Phobia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet